Drug-induced enterocolitis syndrome: Similarities and differences compared with food protein-induced enterocolitis syndrome

Francesca Mori*, Giulia Liccioli, Oliver Fuchs, Simona Barni, Mattia Giovannini, Lucrezia Sarti, Elio Novembre, Jean Christoph Caubet

*Corresponding author for this work

Abstract

In 2014, drug-induced enterocolitis syndrome (DIES) was described for the first time. It is still a poorly known disease with symptoms that typically resemble those of food protein–induced enterocolitis syndrome (FPIES). To date, six more cases of DIES have been described and new clinical diagnostic criteria have been proposed based on those in the international guidelines for FPIES. In this paper, the authors describe three more cases of DIES. In addition, similarities and differences with FPIES have been deeply analyzed. To date, several unanswered questions need to be addressed, but clinicians must be instructed how to identify DIES, in order to make an allergy workup and give definite therapeutic indications to patients, especially in children where DIES seems to be more frequent.

Original languageEnglish
JournalPediatric Allergy and Immunology
Volume32
Issue number6
Pages (from-to)1165-1172
Number of pages8
ISSN0905-6157
DOIs
Publication statusPublished - 08.2021

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Drug-induced enterocolitis syndrome: Similarities and differences compared with food protein-induced enterocolitis syndrome'. Together they form a unique fingerprint.

Cite this